Boston, Massachusetts. Jeff Lange, Virogin Biotech EVP Business Development, will present “New strategies for oncolytic virotherapy: turning anti-viral immunity to anti-tumor” at a session on Novel Combination Therapies to Maximize Anti-Cancer Effectiveness on December 6.